Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea · Delayed Price · Currency is KRW 6,070.00
+30.00 (0.50%)
At close: Sep 5, 2025
Kwang Dong Pharmaceutical Revenue
Kwang Dong Pharmaceutical had revenue of 425.29B KRW in the quarter ending June 30, 2025, with 3.02% growth. This brings the company's revenue in the last twelve months to 1.62T, up 0.68% year-over-year. In the year 2024, Kwang Dong Pharmaceutical had annual revenue of 1.64T with 8.34% growth.
Revenue (ttm)
1,618.31B
Revenue Growth
+0.68%
P/S Ratio
0.15
Revenue / Employee
1.59B
Employees
1,021
Market Cap
238.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,640.72B | 126.26B | 8.34% |
| Dec 31, 2023 | 1,514.45B | 82.91B | 5.79% |
| Dec 31, 2022 | 1,431.55B | 93.36B | 6.98% |
| Dec 31, 2021 | 1,338.18B | 94.41B | 7.59% |
| Dec 31, 2020 | 1,243.77B | 5.51B | 0.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KT&G Corporation | 6,231.77B |
| Samyang Foods | 1,999.91B |
| APR Co., Ltd. | 1,012.10B |
| Amorepacific | 4,141.44B |
| LG H&H | 6,626.30B |
| ORION | 3,215.62B |
| CJ Cheiljedang | 29.35T |
| Dong Suh Companies | 506.17B |